← Back to overview

DVA DaVita Inc.

Health Care Services · $235.44 +0.50%
Price Alert:
Price & Volume
RSI (14)
MACD (12, 26, 9)

Compare

Shows % change over the period so different-priced stocks can be compared fairly.

Technical Indicators

RSI (14)
63.8
Relative Strength Index (RSI): measures how fast and how much the price has moved recently, on a 0-100 scale. Above 70 is often called "overbought" (may be due for a pause or pullback); below 30 is "oversold" (may be due for a bounce). It is not a guarantee either way.
SMA 20 / 50 / 200
230.34 / 211.94 / —
Moving Averages (SMA): the average closing price over the last N days, smoothing out day-to-day noise. When price trades above its moving averages, and shorter averages are above longer ones, it is generally read as a healthier trend.
MACD / Signal
7.42 / 8.60
MACD: compares two moving averages (12-day and 26-day) to gauge momentum. When the MACD line crosses above its signal line, momentum is turning up; crossing below suggests momentum turning down.

Fundamentals

P/E
22.7
Price-to-Earnings ratio: how many dollars investors pay for $1 of the company's annual profit. Higher usually means the market expects faster growth (or the stock is expensive); lower can mean it's cheap — or that growth is expected to slow.
Market Cap
15.11B
Market Capitalization: the total value of all the company's shares — share price × number of shares. A rough measure of company size.
Div Yield
Dividend Yield: the annual cash dividend paid to shareholders, as a percentage of the current share price.
52-Week Range
101.00 – 239.64
52-Week Range: the lowest and highest price the stock has traded at over the last year. Where the price sits in this range hints at recent strength or weakness.

Trend Analysis

DaVita Inc. is trading at $235.44, +0.50% versus the previous close. The price is near its 52-week high — the top of its recent trading range.
RSI is in a neutral range — no strong overbought/oversold signal.
MACD is below its signal line — momentum currently leans negative.
Combine this reading with the fundamentals below before forming a view — no single indicator is a guarantee of what happens next.

Latest News

Moon Capital Management Exited DaVita (DVA) with 174% total Return
Insider Monkey · 2026-07-23 14:33
DaVita Inc. Schedules 2nd Quarter 2026 Investor Conference Call
PR Newswire · 2026-07-21 21:00
3 S&P 500 Stocks We Think Twice About
StockStory · 2026-07-21 12:14
DaVita HealthCare (DVA) Advances While Market Declines: Some Information for Investors
Zacks · 2026-07-17 22:00
3 Profitable Stocks We Think Twice About
StockStory · 2026-07-17 11:05
DaVita HealthCare (DVA) Rises As Market Takes a Dip: Key Facts
Zacks · 2026-07-16 22:15
What You Need To Know Ahead of DaVita’s Earnings Release
Barchart · 2026-07-15 08:30
Truist Raises Price Target on DaVita to $250 From $205, Keeps Hold Rating
MT Newswires · 2026-07-14 11:30
Educational information only. Nothing here is investment advice — always do your own research and consider talking to a licensed financial advisor before buying or selling.
Data: Yahoo Finance, refreshed periodically and cached locally.